Mead Johnson Upbeat On China Outlook After Series Of Setbacks
This article was originally published in The Tan Sheet
Executive Summary
The infant nutritionals firm has put a poorly timed price increase behind it and is optimistic about the effects of a Hong Kong limit on formula exports on China sales. Additionally, a recall of Danone baby nutrition products in Asia is expected to benefit Mead Johnson over the next 9 to 12 months.
You may also be interested in...
Abbott Nutrition Sales Weakened By China Recall
Abbott Nutrition has “invested considerably” in marketing to restore its reputation with consumers after its third-quarter infant formula sales were slowed by a recall in China.
Abbott Nutrition Sales Weakened By China Recall
Abbott Nutrition has “invested considerably” in marketing to restore its reputation with consumers after its third-quarter infant formula sales were slowed by a recall in China.
Mead Johnson Milks Growth Of Emerging Market Middle Class
Mead Johnson sees growth in emerging markets largely because per-birth consumption of infant formula is well below developed regions. The firm invests nearly $100 million in research to provide the pediatric nutritionals innovation sought by parents, VP of Investor Relations Kathy Ann MacDonald says.